Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Hendrikx, Tim ^a   Bieghs, Veerle ^a   Walenbergh, Sofie M A ^a   Van Gorp, Patrick J ^a   Verheyen, Fons ^a   Jeurissen, Mike L J ^a   Steinbusch, Mandy M F ^a   Vaes, Nathalie ^a   Binder, Christoph J ^b,c   Koek, Ger H ^a   Stienstra, Rinke ^d,e   Netea, Mihai G ^d   Hofker, Marten H ^f   Shiri Sverdlov, Ronit ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 11; CHOLESTEROL; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BONE MARROW CELL; CHOLESTEROL INTAKE; CONTROLLED STUDY; CRYSTALLIZATION; DISEASE SEVERITY; ENZYME DEFICIENCY; FEMALE; GENE EXPRESSION; HEPATITIS; HISTOLOGY; HYPERLIPIDEMIA; MACROPHAGE; MOUSE; NONHUMAN; WILD TYPE;

ANIMALS; CASPASE 1; CASPASES; CHOLESTEROL; DIETARY FATS; HEPATITIS; HYPERLIPIDEMIAS; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; KUPFFER CELLS; LIPOPROTEINS, LDL; MICE; MICE, KNOCKOUT;

EID: 84891607476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078792     Document Type: Article

References (46)

1. Farrell GC, van Rooyen D, Gan L, Chitturi S (2012) NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver 6: 149-171. doi:10.5009/gnl.2012.6.2.149. PubMed: 22570745.
2. Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, et al. (2010) Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 138: 2477-2486, e2471-2473
3. Bieghs V, Verheyen F, van Gorp PJ, Hendrikx T, Wouters K et al. (2012) Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. PLOS ONE 7: e34378. doi:10.1371/journal.pone.0034378. PubMed: 22470565.
4. Bieghs V, Hendrikx T, van Gorp PJ, Verheyen F, Guichot YD et al. (2013) The Cholesterol Derivative 27-Hydroxycholesterol Reduces Steatohepatitis in Mice. Gastroenterology, 144: 167-178.e1 PubMed: 23041327.
5. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361. doi:10.1038/ nature08938. PubMed: 20428172.
6. Lukens JR, Dixit VD, Kanneganti TD (2011) Inflammasome activation in obesity-related inflammatory diseases and autoimmunity. Discov Med 12: 65-74. PubMed: 21794210.
7. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 417-426. doi:10.1016/ S1097-2765(02)00599-3. PubMed: 12191486.
8. Stutz A, Golenbock DT, Latz E (2009) Inflammasomes: too big to miss. J Clin Invest 119: 3502-3511. doi:10.1172/JCI40599. PubMed: 19955661.
9. Wang S, Miura M, Jung YK, Zhu H, Li E et al. (1998) Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92: 501-509. doi:10.1016/S0092-8674(00)80943-5. PubMed: 9491891.
10. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479: 117-121. doi:10.1038/nature10558. PubMed: 22002608.
11. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H et al. (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48: 474-486. doi:10.1002/hep.22363. PubMed: 18666236.
12. Wisse E, Braet F, Duimel H, Vreuls C, Koek G et al. (2010) Fixation methods for electron microscopy of human and other liver. World J Gastroenterol 16: 2851-2866. doi:10.3748/wjg.v16.i23.2851. PubMed: 20556830.
13. Jansen HJ, van Essen P, Koenen T, Joosten LA, Netea MG et al. (2012) Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology 153: 5866-5874. doi:10.1210/en.2012-1625. PubMed: 23117929.
14. Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE (2012) Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Lab Invest 92: 713-723. doi:10.1038/labinvest.2012.45. PubMed: 22411067.
15. Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE (2013) Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLOS ONE 8: e56100. doi:10.1371/journal.pone. 0056100. PubMed: 23409132.
16. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ et al. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179-185. PubMed: 22297845.
17. Musso G, Gambino R, Cassader M (2010) Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 33: 2277-2284. doi:10.2337/dc10-0556. PubMed: 20876708.
18. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM et al. (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488: 178-184. doi:10.1038/nature11319. PubMed: 22797518.
19. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, et al. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137: 1716-1724 e1711-1712
20. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I et al. (2009) Autophagy regulates lipid metabolism. Nature 458: 1131-1135. doi:10.1038/ nature07976. PubMed: 19339967.
21. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG et al. (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456: 264-268. doi:10.1038/nature07383. PubMed: 18849965.
22. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M et al. (2012) Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13: 255-263. doi:10.1038/ni.2215. PubMed: 22286270.
23. Harris J, Hartman M, Roche C, Zeng SG, O'Shea A et al. (2011) Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 286: 9587-9597. doi:10.1074/jbc.M110.202911. PubMed: 21228274.
24. Gage J, Hasu M, Thabet M, Whitman SC (2012) Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can J Cardiol 28: 222-229. doi:10.1016/j.cjca.2012.07.331. PubMed: 22265992.
25. Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A et al. (2012) Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun, 425: 162-8. PubMed: 22819845.
26. Aparicio-Vergara M, Shiri-Sverdlov R, de Haan G, Hofker MH (2010) Bone marrow transplantation in mice as a tool for studying the role of hematopoietic cells in metabolic and cardiovascular diseases. Atherosclerosis 213: 335-344. doi:10.1016/j.atherosclerosis. 2010.05.030. PubMed: 20576267.
27. Racanelli V, Rehermann B (2006) The liver as an immunological organ. Hepatology 43: S54-S62. doi:10.1002/hep.21060. PubMed: 16447271.
28. De Nardo D, Latz E (2011) NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 32: 373-379. doi:10.1016/j.it. 2011.05.004. PubMed: 21733753.
29. Bieghs V, Rensen PC, Hofker MH, Shiri-Sverdlov R (2012) NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages. Atherosclerosis 220: 287-293. doi:10.1016/ j.atherosclerosis.2011. 08.041. PubMed: 21930273.
30. Bieghs V, van Gorp PJ, Walenbergh SM, Gijbels MJ, Verheyen F et al. (2012) Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology, 56: 894-903. PubMed: 22334337.
31. Ioannou GN, Haigh WG, Thorning D, Savard C (2013) Hepatic Cholesterol Crystals and Crown-Like Structures Distinguish NASH from Simple Steatosis. J Lipid Res, 54: 1326-34. PubMed: 23417738.
32. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG et al. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9: 857-865. doi:10.1038/ni.1636. PubMed: 18604209.
33. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856. doi:10.1038/ni.1631. PubMed: 18604214.
34. Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10: 210-215. doi:10.1038/nri2725. PubMed: 20168318.
35. Cavelier C, Lorenzi I, Rohrer L, von Eckardstein A (2006) Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim Biophys Acta 1761: 655-666. doi:10.1016/j.bbalip.2006.04.012. PubMed: 16798073.
36. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S et al. (2002) Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22: 630-637. doi:10.1161/01.ATV. 0000014804.35824.DA. PubMed: 11950702.
37. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175. PubMed: 18188003.
38. Ouimet M, Franklin V, Mak E, Liao X, Tabas I et al. (2011) Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab 13: 655-667. doi:10.1016/j.cmet.2011.03.023. PubMed: 21641547.
39. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J et al. (2002) Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 13: 3355-3368. doi:10.1091/mbc.E02-02-0114. PubMed: 12221139.
40. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S et al. (2000) Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406: 906-910. doi:10.1038/35022604. PubMed: 10972294.
41. Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C et al. (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17: 119-129. PubMed: 17913701. Available online at: PubMed: 17913701
42. Razani B, Feng C, Coleman T, Emanuel R, Wen H et al. (2012) Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 15: 534-544. doi:10.1016/j.cmet.2012.02.011. PubMed: 22440612.
43. Singh R, Cuervo AM (2012) Lipophagy: connecting autophagy and lipid metabolism. Int J Cell Biol 2012: 282041
44. Broz P, Monack DM (2013) Noncanonical inflammasomes: caspase-11 activation and effector mechanisms. PLoS Pathog 9: e1003144. PubMed: 23468620.
45. Rajamäki K, Lappalainen J, Oörni K, Välimäki E, Matikainen S et al. (2010) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLOS ONE 5: e11765. doi:10.1371/journal.pone. 0011765. PubMed: 20668705.
46. Akhter A, Caution K, Abu Khweek A, Tazi M, Abdulrahman BA et al. (2012) Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity 37: 35-47. doi:10.1016/j.immuni.2012.05.001. PubMed: 22658523.